About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Validation of HyperDetector for SARS-CoV-2

NCT05124496·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

HyperSpectral APD

Age

5–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Subjects at COVID-19 testing site for Rt-PCR test.

You may not be if

Minors under the age of 5

The record

StatusSuspended

PhaseNo phase

Taking part10,000

StartedDec 2020

UpdatedNov 18, 2021

Conditions

SARS-COV2 Infection

Where1

HyperSpectral APD, LLC
Alexandria, Virginia, United States

Clareo Health | Validation of HyperDetector for SARS-CoV-2